Gritstone Oncology, Inc. (GRTS): Price and Financial Metrics

Gritstone Oncology, Inc. (GRTS): $0.03

0.02 (-31.78%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add GRTS to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#241 of 337

in industry

GRTS Price/Volume Stats

Current price $0.03 52-week high $3.17
Prev. close $0.05 52-week low $0.03
Day low $0.03 Volume 61,017,900
Day high $0.04 Avg. volume 7,014,435
50-day MA $0.40 Dividend yield N/A
200-day MA $1.17 Market Cap 3.50M

GRTS Stock Price Chart Interactive Chart >


Gritstone Oncology, Inc. (GRTS) Company Bio


Gritstone Oncology, Inc., an immuno-oncology company, engages in developing personalized cancer immunotherapies for various cancer types in the United States. It is developing GRANITE-001, a personalized immunotherapy product for cancer patients; and SLATE-001 for patients with common tumor neoantigens. The company was founded in 2015 and is based in Emeryville, California.


GRTS Latest News Stream


Event/Time News Detail
Loading, please wait...

GRTS Latest Social Stream


Loading social stream, please wait...

View Full GRTS Social Stream

GRTS Price Returns

1-mo N/A
3-mo -94.55%
6-mo -96.16%
1-year -98.39%
3-year -99.74%
5-year -99.68%
YTD -98.53%
2023 -40.87%
2022 -73.17%
2021 226.40%
2020 -56.08%
2019 -41.94%

Continue Researching GRTS

Here are a few links from around the web to help you further your research on Gritstone Oncology Inc's stock as an investment opportunity:

Gritstone Oncology Inc (GRTS) Stock Price | Nasdaq
Gritstone Oncology Inc (GRTS) Stock Quote, History and News - Yahoo Finance
Gritstone Oncology Inc (GRTS) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!